FDA Brief

Warning letters Drugs

FDA warning letter to

Central Admixture Pharmacy Services, Inc.

Issued Jul 10, 2024Posted Aug 13, 2024Division of Pharmaceutical Quality Operations IV

Compounding Pharmacy/Adulterated Drug Products. We haven't summarized this letter yet. Read it on fda.gov.

Central Admixture Pharmacy Services, Inc.'s FDA history

  1. Central Admixture Pharmacy Services, Inc.

    CGMP/Drug Products/Adulterated

  2. Central Admixture Pharmacy Services, Inc.

    CGMP/Drug Products/Adulterated

Recalls in the last 12 months

Aug 12 Class III Central Admixture Pharmacy Services Inc
Drug
Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Compound Volume 416.8 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Inc., …
Incorrect Product Formulation
Jul 1 Class II Central Admixture Pharmacy Services, Inc.
Drug
Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Rx# 24-1269856-0-1Compound Volume 1295 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy …
Incorrect product formulation: bag did not contain copper and famotidine per label.

Full company page